SBIR/STTR Research Award
O-ScopeTM - Non-surgical, least-Invasive Diagnostic and Screening for Ovarian Cancer and Endometriosis
Award amount
$749,942Program and phase
SBIR · Phase IIAward year
2022Award details
- Awarding agency
- Department of Defense
- Branch
- Air Force
- Recipient company
- FREYJA HEALTHCARE, LLC
- Proposal award date
- 2022-07-21
- Contract end date
- 2023-10-25
- UEI
- V5F5W6R67JE1
- Solicitation number
- X21.2
- Topic code
- AF212-CSO1
Research abstract
A study investigating the incidence of cancer in the U.S. Air Force found that ovarian cancer was the seventh most prevalent type of cancer among women. U.S. Active-Duty women exhibit a similar age-adjusted rate of gynecologic cancer as the general US population. Among women
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Monitoring Evolution of Coordinated Inauthentic Behavior
- Automated Target Recognition for Rapid Multitarget Grouping, Discrimination and Neutralization
- Composite Binder Enabling Higher Propellant Loading and Performance for Extended Range and Reduced Mass Missile Propulsion
- Video Based Assessment Capabilities and Human Performance Optimization
- Secure, BYOAD Enterprise Talk, Text, Video, and Data Transmission for Air Force Special Operations Command in Communications Denied/Degraded Environments
Research funding history
3 SBIR/STTR records share this UEI (2022–2025). Reported award amounts total $874,488. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense